Supplementary Figure 1 from A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer
Year: 2023
Type: supplementary-materials
Abstract: Visual Depiction of the therapy dosing, and pharmacokinetic (PK) sampling schedule for patients in the Phase I portion of the trial.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361937516